Aimed Alliance
Navigate
  • Home
  • About
    • Mission, Vision, Beliefs
    • Staff
    • Board of Directors
    • Aimed Alliance Supporters
    • Annual Reports
    • Privacy Policy
  • Policy Priorities
  • Initiatives
    • ACTION for PDTs
      • ACTION for PDTs: Mental Health and Substance Use Disorder
    • Alliance for Mental Health Care Access (AMHCA)
    • Alternative Funding Programs
    • Copay Accumulator 101
    • Exocrine Pancreatic Insufficiency Coalition (EPIC)
    • Know Your Rights
    • New York Step Therapy Reform
    • Prescription Drug Affordability Boards
  • Resources
    • All
    • Stakeholders
    • Aimed in the News
    • Health News & Lawsuits
    • Newsletters & Media
  • Maps
    • Bad Drug Ads
      • Active Legislation
      • Enacted Laws
    • Copay Accumulators
      • Active Legislation
      • Enacted Laws
    • Nonmedical Switching
      • Active Legislation
      • Enacted Laws
    • Prior Authorization
      • Active Legislation
      • Enacted Laws
    • Step Therapy
      • Active Legislation
      • Enacted Laws
    • Biomarker Testing
      • Active Legislation
      • Enacted Laws
    • Oral Parity
      • Enacted Laws
  • Events
  • Contact

Aimed Alliance Signs on to Testimony in Opposition to Kan. Bill that Would Reinstate Burdensome Step Therapy Protocols

0
By Aimed Alliance on March 9, 2016 Aimed Activity, Comments & Sign-on Letters, Patients, Caregivers, and Advocates, Policymakers, Resources

Last Updated on May 30, 2019 by

Advocacy State Step Therapy
Share. Twitter Facebook Pinterest LinkedIn Tumblr Email

Related Posts

  • May 1, 2025

    Aimed Alliance & HR.com Launch Menopause in the Workplace Resources

  • May 1, 2025

    Aimed Alliance Urges Oregon PDAB to Ensure Robust Data Collection Process

  • April 22, 2025

    New Resource Tariffs 101: How Tariffs Could Impact Patients

Comments are closed.

  • Aimed Alliance

  • Aimed Alliance is a 501 (c)(3) not-for-profit health policy organization that protects and enhances the rights of health care consumers and professionals.

    • Twitter
    • Facebook
    • Instagram
    • LinkedIn
    • YouTube